Is Adial Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Adial Pharmaceuticals Inc (ADIL) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Adial Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Adial Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Adial Pharmaceuticals Inc?

Muslim investors may consider investing in Adial Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Adial Pharmaceuticals Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Adial Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Adial Pharmaceuticals Inc updated?

The Shariah compliance status of Adial Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Adial Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Adial Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Adial Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ADIL Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 10, 2026

Report Source: 2025 Annual Report

Adial Pharmaceuticals Inc. Stock Analysis ADIL

United States Health Care Nano Cap Report: 2025 Annual

Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. The company is headquartered in Charlottesville, Virginia and currently employs 5 full-time employees. The company went IPO on 2018-07-27. The firm is focused on the development of therapies for the treatment and prevention of addiction and related disorders. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients and was recently investigated in the Company’s ONWARD pivotal Phase III clinical trial for the potential treatment of AUD in subjects with certain target genotypes identified using the Company’s proprietary companion diagnostic genetic test. AD04 is also used for the treatment of other addictive disorders, such as Opioid Use Disorder, obesity, smoking, and other drug addictions. The Company’s wholly owned subsidiary is Purnovate, Inc.

Key Statistics of Adial Pharmaceuticals Inc (ADIL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.31$1.39

Today's Open

$1.36

Volume

81.25K

P/E Ratio (TTM)

52 Week Range

$1.31$440.66

Market Cap

2.28M

Avg. Volume

99.99K

Dividend Yield

Financial Metrics & Statements of Adial Pharmaceuticals Inc (ADIL)

FAQ's for Adial Pharmaceuticals Inc (ADIL)

According to Musaffa’s Shariah screening methodology, Adial Pharmaceuticals Inc (ADIL) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.